David Eansor

2020

In 2020, David Eansor earned a total compensation of $2.7M as Former President, Protein Sciences at Bio-Techne, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$521,387
Option Awards$1,201,974
Salary$552,000
Stock Awards$401,988
Other$8,400
Total$2,685,749

Eansor received $1.2M in option awards, accounting for 45% of the total pay in 2020.

Eansor also received $521.4K in non-equity incentive plan, $552K in salary, $402K in stock awards and $8.4K in other compensation.

Rankings

In 2020, David Eansor's compensation ranked 4,277th out of 13,090 executives tracked by ExecPay. In other words, Eansor earned more than 67.3% of executives.

ClassificationRankingPercentile
All
4,277
out of 13,090
67th
Division
Manufacturing
1,729
out of 5,617
69th
Major group
Chemicals And Allied Products
671
out of 2,248
70th
Industry group
Drugs
574
out of 1,948
71st
Industry
Biological Products, Except Diagnostic Substances
132
out of 411
68th
Source: SEC filing on September 14, 2022.

Eansor's colleagues

We found four more compensation records of executives who worked with David Eansor at Bio-Techne in 2020.

2020

Charles Kummeth

Bio-Techne

Chief Executive Officer

2020

James Hippel

Bio-Techne

Chief Financial Officer

2020

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

2020

Brenda Furlow

Bio-Techne

General Counsel

News

You may also like